Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Accounts Payables (2021 - 2025)

Coeptis Therapeutics Holdings has reported Accounts Payables over the past 5 years, most recently at $888755.0 for Q4 2025.

  • Quarterly results put Accounts Payables at $888755.0 for Q4 2025, down 30.01% from a year ago — trailing twelve months through Dec 2025 was $888755.0 (down 30.01% YoY), and the annual figure for FY2025 was $888755.0, down 30.01%.
  • Accounts Payables for Q4 2025 was $888755.0 at Coeptis Therapeutics Holdings, up from $783103.0 in the prior quarter.
  • Over the last five years, Accounts Payables for COEPW hit a ceiling of $1.4 million in Q4 2023 and a floor of $31816.0 in Q1 2021.
  • Median Accounts Payables over the past 5 years was $835929.0 (2025), compared with a mean of $723537.7.
  • Biggest five-year swings in Accounts Payables: soared 2913.37% in 2022 and later tumbled 65.58% in 2023.
  • Coeptis Therapeutics Holdings' Accounts Payables stood at $134092.0 in 2021, then decreased by 26.15% to $99021.0 in 2022, then skyrocketed by 1333.74% to $1.4 million in 2023, then dropped by 10.56% to $1.3 million in 2024, then plummeted by 30.01% to $888755.0 in 2025.
  • The last three reported values for Accounts Payables were $888755.0 (Q4 2025), $783103.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.